Darryl joined the Ingham Institute in December 2017 as their first CEO. The Ingham Institute is all about addressing health issues in South Western Sydney. Darryl’s focus is primarily around their expansion across the Southwestern Sydney Local Health District, creating new research capabilities, enabling research translation and engaging with industry partners and local communities.
Prior to joining the Ingham Institute Darryl spent nearly 30 years with Johnson & Johnson, most recently as Vice President of Orthopaedics and Neurosurgery and member of the Johnson & Johnson Medical Australia & New Zealand Board. During his career Darryl had a number of overseas postings which included leading the Ortho Clinical Diagnostics businesses in Asia Pacific and being a member of their Global Management Board.
His business experience also includes leadership of Johnson & Johnson companies working in bariatrics, minimally invasive surgery, low temperature sterilisation, hand hygiene and cardiology. These diverse roles provided many opportunities to work with leading clinicians as new technologies were developed, evaluated and eventually made available to treat patients.
Darryl served two terms on the Board of the Medical Technology Association of Australia including one term as Treasurer. He was fortunate to be involved in many of Johnson & Johnson’s community initiatives and served as chair of their Diversity & Inclusion Council.